Table 2.
Organ | Diagnosis | n | % |
---|---|---|---|
Lung | Pulmonary capillary congestion | 21/21 | 100 |
DAD, exudative | 16/21 | 76 | |
DAD, proliferative | 8/21 | 38 | |
Reactive pneumocytes and syncytial cells | 11/21 | 52 | |
Microthrombi of alveolar capillaries | 5/11 | 45 | |
Bronchopneumonia, diffuse | 6/21 | 29 | |
Bronchopneumonia, focal | 4/21 | 19 | |
Severe mucous tracheitis | 6/21 | 29 | |
Emphysema | 6/21 | 29 | |
Pulmonary embolism | 4/21 | 19 | |
Prominent lymphoid infiltrates | 3/21 | 14 | |
Pulmonary haemorrhage | 3/21 | 14 | |
Amyloidosis of pulmonary vessels | 3/21 | 14 | |
Vasculitis | 1/21 | 5 | |
Heart | Myocardial hypertrophy | 15/21 | 71 |
Senile amyloidosis | 6/21 | 29 | |
Peracute myocardial cell necrosis | 3/21 | 14 | |
Acute myocardial infarction | 1/21 | 5 | |
Kidney | Acute tubular damage | 14/15 | 93 |
Disseminated intravascular coagulation | 3/17 | 18 | |
Hypertensive nephropathy | 2/17 | 12 | |
Diabetic nephropathy | 2/17 | 12 | |
Liver | Steatosis | 7/17 | 41 |
Shock necrosis | 5/17 | 29 | |
ASH/NASH | 3/17 | 18 | |
Lymph node | Increased presence of plasmablasts | 5/9 | 56 |
Congestion | 6/9 | 67 | |
Spleen | Acute splenitis | 6/21 | 29 |
Bone marrow | Reactive left shift of myelopoiesis | 3/5 | 60 |
Involvement by haematopoietic malignancies | 2/5 | 40 |
ASH, alcoholic steatohepatitis; DAD, diffuse alveolar damage; NASH, non‐alcoholic steatohepatitis.